NLS Finland

The Finnish biotech company developing stem cell therapies for vision restoration, has raised funding from Voima Ventures, Finnish family offices (Stephen Industries Inc. & Biothom Oy), private investors, and Business Finland.

Some of the leading Finnish businesses in the cleanroom sector have formed a working partnership to offer complete solutions in international cleanroom markets, with particular emphasis on sustainability.

The European High Performance Computing Joint Undertaking (EuroHPC) has selected seven proposals to establish and operate the first AI Factories across Europe, and two of them are located in the Nordic region. 

Rappta Therapeutics has announced an exclusive global license agreement with SpringWorks Therapeutics for RPT04402, a first-in-class molecular glue of specific Protein Phosphatase 2A (PP2A) complexes. 

Orion Corporation and Marinus Pharmaceuticals have decided to mutually terminate their European wide marketing and distribution agreement for ganaxolone.